STOCK OPTIONS

12 Months Ended

Jun. 30, 2021

Disclosure Text Block Supplement [Abstract]

Shareholders' Equity and Share-based Payments [Text Block]

NOTE 5 – STOCK OPTIONS

General Option Information

On July 22, 2020, the Board of Directors adopted the 2020 Equity Incentive Plan (the “2020 Plan”) which contains provisions for up to 5,000,000 stock-based instruments to be granted to employees, consultants and directors. The plan includes the stock awards as described in Note 4 above, and any options which may be contemplated in the future.

No options have been granted as of in fiscal year 2021 or fiscal year 2020.  

A summary of the status of our outstanding stock options as of June 30, 2021 and June 30, 2020 and changes during the years then ended is presented below: 

	June 30, 2021							June 30, 2020
				Weight Average		Intrinsic					Weight Average		Intrinsic
	Shares			Exercise Price		Value		Shares			Exercise Price		Value
Outstanding beginning of period		2,870,000		$	0.12				3,970,000		$	0.12
Granted		-		$	0.00				-		$	0.00
Expired/Cancelled		(1,840,000	)	$	0.12				(1,100,000	)	$	0.14
Exercised		-		$	0.00				-		$	0.00
Outstanding end of period		1,030,000		$	0.12	$	-		2,870,000		$	0.12	$	-
Exercisable		1,030,000		$	0.12	$	-		2,870,000		$	0.12	$	-

The following table summarizes the range of outstanding and exercisable options as of June 30, 2021:

		Outstanding						Exercisable
Range of Exercise Prices		Number Outstanding at June 30, 2021		Weighted Average Remaining Contractual Life		Weighted Average Exercise Price		Number Exercisable at June 30, 2021		Weighted Average Remaining Contractual Life
$	0.08		150,000		0.42	$	0.08		150,000		0.42
$	0.10		480,000		0.50	$	0.10		480,000		0.50
$	0.17		400,000		0.42	$	0.17		400,000		0.42
			1,030,000						1,030,000